Literature DB >> 8077677

Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils.

T van der Bruggen1, P T Kok, J A Raaijmakers, J W Lammers, L Koenderman.   

Abstract

After priming with cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3, or IL-5, eosinophils are stimulated potently by opsonized particles like serum-treated zymosan (STZ), resulting in activation of the respiratory burst and production of lipid mediators, such as platelet-activating factor (PAF) and leukotriene C4 (LTC4). In the present study, the role of the opsonin receptors Fc gamma RII and CR3 during both STZ-induced activation of the respiratory burst and PAF release by human eosinophils was investigated. Inhibition studies with blocking mAbs (alpha hFc gamma RII: AT10, IV.3; alpha CR3: B2.12, 44a) showed that both Fc gamma RII and CR3 are important for STZ-induced PAF release by cytokine-primed eosinophils. In contrast, CR3 is involved in activation of the respiratory burst, whereas Fc gamma RII seems not to be important, because blocking anti-Fc gamma RII mAbs had no effect. Subsequently, experiments were performed with zymosan particles coated with IgG, iC3b, or a combination of both. IgG-coated particles poorly activated both responses in GM-CSF primed and unprimed cells. iC3b-Zymosan activated the respiratory burst as well as zymosan expressing both opsonins (IgG/iC3b-zymosan). In contrast, iC3b-zymosan induced significantly less PAF release by GM-CSF-primed eosinophils than did IgG/iC3b-zymosan, suggesting synergism between Fc gamma RII and CR3. This synergistic effect was not observed when IgG-zymosan and iC3b-zymosan were added simultaneously. Therefore, these data indicate that on human eosinophils, Fc gamma RII and CR3 act synergistically to activate PAF release, provided that their ligands are in close proximity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils.

Authors:  A T Tool; M Blom; D Roos; A J Verhoeven
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 3.  Interactions of integrins with their partner proteins in leukocyte membranes.

Authors:  Howard R Petty; Randall G Worth; Robert F Todd
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.

Authors:  André Klein; Vanessa Pinho; Ana Letícia Alessandrini; Takao Shimizu; Satoshi Ishii; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated L-plastin.

Authors:  Konrad Pazdrak; Travis W Young; Christof Straub; Susan Stafford; Alexander Kurosky
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

6.  Cigarette smoke induces β2-integrin-dependent neutrophil migration across human endothelium.

Authors:  Saskia A Overbeek; Saskia Braber; Paul A J Henricks; Marije Kleinjan; Vera M Kamp; Niki A Georgiou; Johan Garssen; Aletta D Kraneveld; Gert Folkerts
Journal:  Respir Res       Date:  2011-06-08

Review 7.  Inside-Out Control of Fc-Receptors.

Authors:  Leo Koenderman
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

8.  Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.

Authors:  Haizhang Chen; Andrea Maul-Pavicic; Martin Holzer; Magdalena Huber; Ulrich Salzer; Nina Chevalier; Reinhard E Voll; Hartmut Hengel; Philipp Kolb
Journal:  EMBO Mol Med       Date:  2021-11-29       Impact factor: 12.137

9.  Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.

Authors:  Sanjay Khandelwal; Ayiesha Barnes; Lubica Rauova; Amrita Sarkar; Ann H Rux; Serge V Yarovoi; S Sergei Zaitsev; John D Lambris; Sooho S Myoung; Alexandra Johnson; Grace M Lee; Madelaine Duarte; Mortimer Poncz; Gowthami M Arepally; Douglas B Cines
Journal:  Blood       Date:  2021-11-25       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.